Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice.
Hepatology. 2022 Jan;75(1):140-153. doi: 10.1002/hep.32148. Epub 2021 Nov 27.
Hepatology. 2022.
PMID: 34510514